Skip to Main Content

Long-Acting Injectables

Description

Created by our Medical Director and Director of Pharmacy, this pre-recorded presentation is intended for prescribers. This training event will help prescribers understand how antipsychotic medication adherence decreases relapse, readmissions and hospitalization.

Learning Objectives

  • Identify the different types of medications used to treat schizophrenia, schizoaffective disorder, bipolar disorder with psychotic features, and other psychotic disorders.
  • Understand common antipsychotic side effects, the importance of routine monitoring, and the program improvement project for diabetes screening.
  • Identify barriers that may prevent members from taking long acting injectable antipsychotic (LAIA) medications.
  • Utilize clinical insights to ensure members at greatest risk for readmission and relapse are initiated on an LAIA prior to discharge

This pre-recorded training is approximately 45 minutes in length. If you have any questions, please submit them to our Pharmacy mailbox prior to the event.
Note: This course is NOT eligible for continuing education credits for any licenses.

Register to access the on-demand training, Long-Acting Injectables: Preventing Readmissions.